Eli Lilly has shared promising results from its large-scale study comparing Mounjaro (tirzepatide) with Trulicity (dulaglutide) in adults with type […]

Even with recent uncertainties, big pharmaceutical companies continue to focus on business deals to keep growing. Factors like upcoming tariffs,

Novo Nordisk, a leading pharmaceutical company known for its weight-loss and diabetes drugs, has appointed Maziar Mike Doustdar as its

Roche, a major pharmaceutical company, is making big moves in the obesity drug market. Earlier this year, they partnered with

A new treatment combining KEYTRUDA (pembrolizumab) with chemotherapy has been recommended by NICE for adults with advanced or recurrent womb

The Food and Drug Administration (FDA) has introduced a new program called ‘FDA PreCheck’ to help strengthen U.S. drug production.

Exonate, a pharmaceutical company, has announced plans to start a phase 2b clinical trial for its lead drug, EXN407, in

Dr. George Tidmarsh, a physician, academic, and biotech entrepreneur, has been appointed as the new director of the FDA’s Center

AstraZeneca has received a positive recommendation from NICE (the National Institute for Health and Care Excellence) for a new combination

President Donald Trump has warned 17 major drug companies that they must lower their prices to match those in other